ZIG
IONS icon

Zurich Insurance Group’s Ionis Pharmaceuticals IONS Stock Holding History

Zurich Insurance Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18M Sell
239,645
-22,175
-8% -$1.75M 0.14% 175
2025
Q4 		$20.7M Buy
+261,820
New +$19.7M 0.14% 149

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zurich Insurance Group's IONS Position: Q1 2026 in Review

Zurich Insurance Group reduced its Ionis Pharmaceuticals (IONS) stake by 8.5% in Q1 2026, selling an estimated $1.75M and leaving 239,645 shares worth $18M. The position accounts for 0.14% of the portfolio, ranked #175.

Zurich Insurance Group first reported a position in IONS in Q4 2025 and has held it in 2 quarters since. The position peaked at $20.7M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Zurich Insurance Group held 239,645 shares of Ionis Pharmaceuticals worth $18M as of Q1 2026.
  • Zurich Insurance Group sold 22,175 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.75M.
  • Ionis Pharmaceuticals made up 0.14% of Zurich Insurance Group's portfolio in Q1 2026, its #175 holding.
  • Zurich Insurance Group first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Zurich Insurance Group's Ionis Pharmaceuticals position peaked at $20.7M in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Zurich Insurance Group's 13F filing for Q1 2026, filed 15 May 2026.